These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 27030118)

  • 61. [To observe, or to observe and to act?].
    Slama G
    Ann Endocrinol (Paris); 2003 Jun; 64(3 Suppl):S27-31. PubMed ID: 12910056
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Re-thinking metabolic strategies for older people with type 2 diabetes mellitus: implications of the UK Prospective Diabetes Study and other recent studies.
    Sinclair AJ; Meneilly GS
    Age Ageing; 2000 Sep; 29(5):393-7. PubMed ID: 11108410
    [No Abstract]   [Full Text] [Related]  

  • 63. An algorithm for the care of type 2 diabetes.
    Cole A; Nathan DM; Savaria-Porter E; Copeland P; Turchin A; Brunt M; Zusman R; Barrett JA; Wexler D; Case E; McMahon GT; Mort E
    Crit Pathw Cardiol; 2009 Dec; 8(4):156-65. PubMed ID: 19952550
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Medical director responsibilities for outpatient cardiac rehabilitation/secondary prevention programs: 2012 update: a statement for health care professionals from the American Association of Cardiovascular and Pulmonary Rehabilitation and the American Heart Association.
    King M; Bittner V; Josephson R; Lui K; Thomas RJ; Williams MA
    Circulation; 2012 Nov; 126(21):2535-43. PubMed ID: 23091064
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Patient-centered and practical application of new high cholesterol guidelines to prevent cardiovascular disease.
    Montori VM; Brito JP; Ting HH
    JAMA; 2014 Feb; 311(5):465-6. PubMed ID: 24496532
    [No Abstract]   [Full Text] [Related]  

  • 66. National Kidney Foundation consensus conference on cardiovascular and kidney diseases and diabetes risk: an integrated therapeutic approach to reduce events.
    Bakris G; Vassalotti J; Ritz E; Wanner C; Stergiou G; Molitch M; Nesto R; Kaysen GA; Sowers JR;
    Kidney Int; 2010 Oct; 78(8):726-36. PubMed ID: 20720529
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Early and more vigorous detection of diabetes.
    Lamendola C
    J Cardiovasc Nurs; 2003; 18(2):103-7. PubMed ID: 12680568
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Guidelines for the Reduction of Cardiovascular Disease in Women.
    Lundberg GP; Dunbar SB; Wenger NK
    J Obstet Gynecol Neonatal Nurs; 2016; 45(3):402-12. PubMed ID: 26993208
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Diabetes mellitus, coronary artery disease und heart disease (Update 2019)].
    Clodi M; Saely CH; Hoppichler F; Resl M; Steinwender C; Stingl H; Wascher TC; Winhofer-Stöckl Y; Sourij H
    Wien Klin Wochenschr; 2019 May; 131(Suppl 1):169-173. PubMed ID: 30980152
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary.
    ; ; Grundy SM; Cleeman JI; Daniels SR; Donato KA; Eckel RH; Franklin BA; Gordon DJ; Krauss RM; Savage PJ; Smith SC; Spertus JA; Costa F
    Cardiol Rev; 2005; 13(6):322-7. PubMed ID: 16708441
    [No Abstract]   [Full Text] [Related]  

  • 71. Diabetes and cardiovascular disease: a statement for healthcare professionals from the American Heart Association.
    Grundy SM; Benjamin IJ; Burke GL; Chait A; Eckel RH; Howard BV; Mitch W; Smith SC; Sowers JR
    Circulation; 1999 Sep; 100(10):1134-46. PubMed ID: 10477542
    [No Abstract]   [Full Text] [Related]  

  • 72. Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association.
    Eyre H; Kahn R; Robertson RM;
    Diabetes Care; 2004 Jul; 27(7):1812-24. PubMed ID: 15220271
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Natural history of cardiovascular and renal disease in patients with type 2 diabetes: effect of therapeutic interventions and risk modification.
    Mogensen CE
    Am J Cardiol; 1998 Nov; 82(9B):4R-8R. PubMed ID: 9822136
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Management of cardiovascular risk factors in type 2 diabetes mellitus].
    Brändle M; Spinas GA
    Ther Umsch; 2002 Aug; 59(8):415-21. PubMed ID: 12235734
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Type 2 Diabetes Mellitus and Heart Failure, A Scientific Statement From the American Heart Association and Heart Failure Society of America.
    Dunlay SM; Givertz MM; Aguilar D; Allen LA; Chan M; Desai AS; Deswal A; Dickson VV; Kosiborod MN; Lekavich CL; McCoy RG; Mentz RJ; PiÑa IL; ; ;
    J Card Fail; 2019 Aug; 25(8):584-619. PubMed ID: 31174952
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Secondary prevention of cardiovascular disease and diabetes: still suboptimal in patients with myocardial infarction.
    Chin BS; Kharim S; Ghaffar A; Rehman A; Lip GY
    J Intern Med; 2001 Aug; 250(2):180-2. PubMed ID: 11489070
    [No Abstract]   [Full Text] [Related]  

  • 77. Obesity, insulin resistance, and microvascular adaptation.
    Frisbee JC
    Microcirculation; 2017 Feb; 24(2):. PubMed ID: 27987530
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Hyperglycaemia as a cardiovascular risk factor in diabetes.
    Yudkin JS
    Lancet; 2008 Sep; 372(9643):1036-7. PubMed ID: 18805326
    [No Abstract]   [Full Text] [Related]  

  • 79. Broader metabolic control in diabetes management.
    Taskinen MR
    Diabetes Metab Rev; 1998 Sep; 14 Suppl 1():S39-43. PubMed ID: 9816486
    [No Abstract]   [Full Text] [Related]  

  • 80. Therapeutic objectives and their practical achievement in type 2 diabetes.
    Keen H
    J Diabetes Complications; 2000; 14(4):180-4. PubMed ID: 11004425
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.